A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
The CRISPR-based drug development platforms market capitalizes on the growing demand for precision medicine and gene editing advancements, especially in oncology. Opportunities lie in enhanced drug ...
6d
CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
From gene-editing breakthroughs to blockbuster cystic fibrosis drugs, these two industry leaders present sharply contrasting ...
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
New Scientist on MSN
I’m the first person whose life was saved by CRISPR base editing
When standard leukaemia treatments failed, 13-year-old Alyssa Tapley was told she had only weeks left – but then she was ...
The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.
The use of genome editing in early embryos has pulled back the curtain on the role of one of the key genes that orchestrates ...
Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...
A team of researchers led by Professor Akitsu Hotta (Department of Clinical Application) developed a comprehensive framework ...
Banas is associate director of research at the Gene Editing Institute at ChristianaCare, where Kmiec is founder and executive director. The medical promise of CRISPR gene editing can be seen most ...
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...
In a rapidly changing climate landscape, the plants we rely on for food, textiles and more face a multitude of challenges, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results